Acute hemolytic transfusion reaction caused by anti-Yta
By: M. Raos, N. Thornton, M. Lukic and B. Golubic Cepulic
Paid access
|Mar 2021❗ Available for purchase in USD only.
❗ Available for purchase in USD only.
References
- Storry JR, Clausen FB, Castilho L, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: report of the Dubai, Copenhagen and Toronto meetings. Vox Sang 2019;114:95–102.
- Daniels G. Human blood groups. 3rd ed. Oxford: Blackwell Publishing, 2013.
- Reid M, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. San Diego, CA: Academic Press, 2012.
- Eaton BR, Morton JA, Pickels MM, White KE. A new antibody, anti-Yta, characterizing a blood group of high incidence. Br J Haematol 1956;2:333–41.
- Gale SA, Rowe GP, Northfield FE. Application of a microtiter plate antiglobulin technique to determine the incidence of donors lacking high frequency antigens. Vox Sang 1988;54: 172–3.
- Giles CM, Matax-Bühler M, Romanski Y, Metaxas MN. Studies on the Yt blood group system. Vox Sang 1967;13:171–80.
- Levene C, Bar-Shany S, Manny N, Moulds JJ, Cohen T. The Yt blood groups in Israeli Jews, Arabs, and Druse. Transfusion 1987;27:471–4.
- Tossas E, Baxter M, Reid ME, Charles-Pierre D, Lomas-Francis C. Prevalence of Yt(a–) in Hispanic blood donors. Immunohematology 2008;24:27.
- Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.
- Arndt PA, Garratty G. A retrospective analysis of the value of the monocyte monolayer assay results for predicting clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.
- Hadley A, Wilkes A, Poole J, Arndt P, Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999;9:337–42.
- Bettigole R, Harris JP, Tegoli J, Issitt PD. Rapid in vivo destruction of Yt(a+) red cells in a patient with anti-Yta. Vox Sang 1968;14:143–6.
- Göbel U, Drescher H, Pöttgen W, Lehr HJ. A second example of anti-Yta with rapid in vivo destruction of Yt(a+) red cells. Vox Sang 1974;27:171–5.
- Ballas SK, Sherwood WC. Rapid in vivo destruction of Yt(a+) erythrocytes in a recipient with anti-Yta. Transfusion 1976;17:65–6.
- Dobbs JV, Prutting DL, Adebahr ME, Allen FH Jr, Alter AA. Clinical experience with three examples of anti-Yta. Vox Sang 1968;15:216–21.
- Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 12th ed. Oxford: Blackwell Publishing, 2014.
- Pierce SR, Hardman JT, Hunt JS, Beck ML. Anti-Yta: characterization by IgG subclass composition and macrophage assay. Transfusion 1980;20:627–8.
- Vengelen-Tyler V, Morel PA. Serologic and IgG subclass characterization of Cartwright (Yt) and Gerbich (Ge) antibodies. Transfusion 1983;23:114–6.
- AuBuchon JP, Brightman A, Anderson HJ, Kim B. An example of anti-Yta demonstrating a change in its clinical significance. Vox Sang 1988;55:171–5.
- Mohandas K, Spivack M, Delehanty CL. Management of patients with anti-Cartwright (Yta). Transfusion 1985;25: 381–4.
- Sacks DA, Johnson CS. Yta isoimmunization in pregnancy: a case report. J Reprod Med 1983;28:407–9.
- Nugent CE, Gelinas JR, Judd WJ, Steiner EA. Anti-Yta does not cause hemolytic disease of the newborn. Obstet Gynecol 1992;79:872–3.
- Eckrich RJ, Mallory D, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta. Immunohematology 1995;11: 81–4.
DOI: https://doi.org/10.21307/immunohematology-2021-003 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 13 - 17
Published on: Mar 31, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 M. Raos, N. Thornton, M. Lukic, B. Golubic Cepulic, published by American National Red Cross
This work is licensed under the Creative Commons License.